Karen L. Andrews

Trends in rehabilitation after amputation for geriatric patients with vascular disease: implications for future health resource allocation.

NO and the vasculature: where does it come from and what does it do?

A photosensitive vascular smooth muscle store of nitric oxide in mouse aorta: no dependence on expression of endothelial nitric oxide synthase.

Novel imidazoline compounds that inhibit Kir-mediated vasorelaxation in rat middle cerebral artery.

The vascular endothelium in diabetes: a practical target for drug treatment?

Expedited wound healing with noncontact, low-frequency ultrasound therapy in chronic wounds: a retrospective analysis.

Nitroxyl (HNO): the Cinderella of the nitric oxide story.

Using a silver-coated polymeric substrate for the management of chronic ulcerations: the initial Mayo Clinic experience.

A role for nitroxyl (HNO) as an endothelium-derived relaxing and hyperpolarizing factor in resistance arteries.

Arginase II knockout mouse displays a hypertensive phenotype despite a decreased vasoconstrictory profile.

Quality performance measures: the tie that binds reimbursement, licensure, certification, and continuing medical education.

Anti-atherogenic effects of high-density lipoprotein on nitric oxide synthesis in the endothelium.

Nitroxyl (HNO) as a vasoprotective signaling molecule.

The use of elevation and dependency to enhance the predictive value of transcutaneous oxygen pressure measurements in the assessment of foot amputation healing.

Endothelial dysfunction in hypertension: the role of arginase.

The at-risk foot: what to do before and after amputation.